These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 27157611)

  • 1. Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5.
    Wang S; Pan Y; Zhang R; Xu T; Wu W; Zhang R; Wang C; Huang H; Calin CA; Yang H; Claret FX
    Oncogene; 2016 Nov; 35(47):6096-6108. PubMed ID: 27157611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression.
    Pan Y; Wang S; Su B; Zhou F; Zhang R; Xu T; Zhang R; Leventaki V; Drakos E; Liu W; Claret FX
    Oncogene; 2017 Feb; 36(8):1069-1079. PubMed ID: 27524414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways.
    Pan Y; Zhang Q; Atsaves V; Yang H; Claret FX
    Oncogene; 2013 May; 32(22):2756-66. PubMed ID: 22797071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
    Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
    J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer.
    Wang S; Oh DY; Leventaki V; Drakos E; Zhang R; Sahin AA; Resetkova E; Edgerton ME; Wu W; Claret FX
    Cancer Lett; 2019 Nov; 465():12-23. PubMed ID: 31473252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNA-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting IL8/AKT Signaling.
    Qu JQ; Yi HM; Ye X; Zhu JF; Yi H; Li LN; Xiao T; Yuan L; Li JY; Wang YY; Feng J; He QY; Lu SS; Xiao ZQ
    Mol Cancer Ther; 2015 Nov; 14(11):2653-64. PubMed ID: 26304234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin analogue T83 exhibits potent antitumor activity and induces radiosensitivity through inactivation of Jab1 in nasopharyngeal carcinoma.
    Pan Y; Wang M; Bu X; Zuo Y; Wang S; Wang D; Liu Q; Su B; Xu T; Wang C; Claret FX; Yang H
    BMC Cancer; 2013 Jul; 13():323. PubMed ID: 23815987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway.
    Qu JQ; Yi HM; Ye X; Li LN; Zhu JF; Xiao T; Yuan L; Li JY; Wang YY; Feng J; He QY; Lu SS; Yi H; Xiao ZQ
    Oncotarget; 2015 Sep; 6(29):28341-56. PubMed ID: 26314966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-17-5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21.
    Chen C; Lu Z; Yang J; Hao W; Qin Y; Wang H; Xie C; Xie R
    Cancer Med; 2016 Dec; 5(12):3489-3499. PubMed ID: 27774777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance by Targeting A20/NF-κB Signaling Pathway.
    Li LN; Xiao T; Yi HM; Zheng Z; Qu JQ; Huang W; Ye X; Yi H; Lu SS; Li XH; Xiao ZQ
    Mol Cancer Ther; 2017 Oct; 16(10):2094-2106. PubMed ID: 28698199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Jab1/CSN5 in nasopharyngeal carcinoma.
    Pan Y; Claret FX
    Cancer Lett; 2012 Dec; 326(2):155-60. PubMed ID: 22867945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-24 enhances radiosensitivity in nasopharyngeal carcinoma by targeting SP1.
    Kang M; Xiao J; Wang J; Zhou P; Wei T; Zhao T; Wang R
    Cancer Med; 2016 Jun; 5(6):1163-73. PubMed ID: 26922862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-101 sensitizes human nasopharyngeal carcinoma cells to radiation by targeting stathmin 1.
    Sun Q; Liu T; Zhang T; Du S; Xie GX; Lin X; Chen L; Yuan Y
    Mol Med Rep; 2015 May; 11(5):3330-6. PubMed ID: 25607713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of lncRNA ANRIL inhibits proliferation, induces apoptosis, and enhances radiosensitivity in nasopharyngeal carcinoma cells through regulating miR-125a.
    Hu X; Jiang H; Jiang X
    Cancer Biol Ther; 2017 May; 18(5):331-338. PubMed ID: 28402230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-150 contributes to the radioresistance in nasopharyngeal carcinoma cells by targeting glycogen synthase kinase-3β.
    Huang Y; Tan D; Xiao J; Li Q; Zhang X; Luo Z
    J Cancer Res Ther; 2018 Jan; 14(1):111-118. PubMed ID: 29516971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-451 increases radiosensitivity of nasopharyngeal carcinoma cells by targeting ras-related protein 14 (RAB14).
    Zhang T; Sun Q; Liu T; Chen J; Du S; Ren C; Liao G; Yuan Y
    Tumour Biol; 2014 Dec; 35(12):12593-9. PubMed ID: 25201065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
    Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
    J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-483-5p decreases the radiosensitivity of nasopharyngeal carcinoma cells by targeting DAPK1.
    Tian Y; Yan M; Zheng J; Li R; Lin J; Xu A; Liang Y; Zheng R; Yuan Y
    Lab Invest; 2019 May; 99(5):602-611. PubMed ID: 30664712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR‑495 enhances the efficacy of radiotherapy by targeting GRP78 to regulate EMT in nasopharyngeal carcinoma cells.
    Feng X; Lv W; Wang S; He Q
    Oncol Rep; 2018 Sep; 40(3):1223-1232. PubMed ID: 30015969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3.
    Xu S; Zhao N; Hui L; Song M; Miao ZW; Jiang XJ
    Oncol Rep; 2016 Mar; 35(3):1385-94. PubMed ID: 26707908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.